General Psychiatry - Articles - Page 41

Auvelity: 4 Controversies

February 12, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.

Auvelity A Fast Acting Antidepressant

February 5, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depression

CME Post-Test, Bipolar Depression, TCPR, February 2024

February 1, 2024

By successfully completing the test you will be awarded a certificate for 1 CME credit.

Research Update

PEA: A Natural Anti-Inflammatory for Mania?

February 1, 2024

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

After encouraging results in depression, the natural therapy palmitoylethanolamide (PEA) undergoes a randomized controlled trial in bipolar mania.

Clinical Update

New Medications for Insomnia

February 1, 2024

Garrett Rossi, MD.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.
Dr. Rossi has no financial relationships with companies related to this material.

The orexin antagonist—daridorexant, lemborexant, and suvorexant—may be safer than traditional hypnotics, but how well do they work?

Expert Q&A

Lithium, Antidepressants, and Bipolar Disorder

February 1, 2024

Michael J. Gitlin, M.D.

Michael J. Gitlin, MD.

Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).

Dr. Gitlin has no financial relationships with companies related to this material.

Practical updates on lithium, antipsychotics, and antidepressants in bipolar disorder.

Clinical Update

Six Recent Disappointments in Psychiatric Research

February 1, 2024

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Find out where standard therapies like cariprazine and esketamine have failed in recent trials, along with novel medications like minocycline, zuranolone, pimavanserin, and NAC.

Clinical Guidance

Syphilis in Psychiatry

January 31, 2024

Daniel Carlat, MD

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Syphilis, often termed the "great imitator," is a sexually transmitted infection (STI) that can present symptoms similar to many other conditions, including psychotic and mood disorders. Here we review its stages, diagnosis, and treatment.

Clinical Guidance